Last 12 months
Inside the activity.
0 purchase rows · 50 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 3 |
| Dec 2025 | 0 | 1 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 23 |
| Mar 2026 | 0 | 1 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 1 |
| Jun 2026 | 0 | 1 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 15 |
| Sep 2026 | 0 | 5 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 11, 2026 Filed Feb 13, 2026 01:56 UTC |
Smith Hunter CChief Financial Officer
|
GrantStock Options (Right to Buy) · Derivative | 37,500 | $0.00 Strike: $98.47 | $0.00 |
DisclosureSEC source: 0001104659-26-014546 · tm266263-1_4seq1.xml · derivative · entry 12 Smith Hunter C · CIK 0001636385 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 37,500 Underlying: Common Stock · 37,500 shares Expires 2036-02-10 F12 · derivative.exercise_date: The stock options were granted on February 11, 2026. The options vest and become exercisable in 16 substantially equal installments upon the Reporting Person's completion of each three full months of successive service to the Issuer following the grant date. Read SEC document |
| February 11, 2026 Filed Feb 13, 2026 01:56 UTC |
Smith Hunter CChief Financial Officer
|
GrantRestricted Stock Units · Derivative | 25,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-26-014546 · tm266263-1_4seq1.xml · derivative · entry 11 Smith Hunter C · CIK 0001636385 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 25,000 Underlying: Common Stock · 25,000 shares Expires not disclosed F10 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Issuer common stock. F11 · derivative.exercise_date: The restricted stock units vest as to 25% of the total shares on each of February 1, 2027, February 1, 2028, February 1, 2029 and February 1, 2030. The restricted stock units have no expiration date. F11 · derivative.expiration_date: The restricted stock units vest as to 25% of the total shares on each of February 1, 2027, February 1, 2028, February 1, 2029 and February 1, 2030. The restricted stock units have no expiration date. Read SEC document |
| February 11, 2026 Filed Feb 13, 2026 01:56 UTC |
Smith Hunter CChief Financial Officer
|
SaleCommon Stock | 100 | $100.85 | $10,085.27 |
DisclosureSEC source: 0001104659-26-014546 · tm266263-1_4seq1.xml · nonDerivative · entry 6 Smith Hunter C · CIK 0001636385 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 120,058 F1 · kind: The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on February 28, 2025. F6 · price: The price reported in Column 4 is a weighted average price. The securities were sold in multiple transactions at prices ranging from $100.49 to $100.98 per common stock. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| February 11, 2026 Filed Feb 13, 2026 01:56 UTC |
Smith Hunter CChief Financial Officer
|
SaleCommon Stock | 400 | $99.44 | $39,774.72 |
DisclosureSEC source: 0001104659-26-014546 · tm266263-1_4seq1.xml · nonDerivative · entry 5 Smith Hunter C · CIK 0001636385 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 120,158 F1 · kind: The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on February 28, 2025. F5 · price: The price reported in Column 4 is a weighted average price. The securities were sold in multiple transactions at prices ranging from $98.89 to $99.88 per common stock. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| February 11, 2026 Filed Feb 13, 2026 01:56 UTC |
Smith Hunter CChief Financial Officer
|
SaleCommon Stock | 2,266 | $98.37 | $222,906.42 |
DisclosureSEC source: 0001104659-26-014546 · tm266263-1_4seq1.xml · nonDerivative · entry 4 Smith Hunter C · CIK 0001636385 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 120,558 F1 · kind: The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on February 28, 2025. F4 · price: The price reported in Column 4 is a weighted average price. The securities were sold in multiple transactions at prices ranging from $97.80 to $98.79 per common stock. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| February 11, 2026 Filed Feb 13, 2026 22:47 UTC |
Garfield AlastairChief Scientific Officer
|
GrantStock Options (Right to Buy) · Derivative | 25,000 | $0.00 Strike: $98.47 | $0.00 |
DisclosureSEC source: 0001104659-26-015397 · tm266366-2_4seq1.xml · derivative · entry 2 Garfield Alastair · CIK 0002027261 · Chief Scientific Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,000 Underlying: Common Stock · 25,000 shares Expires 2036-02-10 F3 · derivative.exercise_date: The stock options were granted on February 11, 2026. The options vest and become exercisable in 16 substantially equal installments upon the Reporting Person's completion of each three full months of successive service to the Issuer following the grant date. Read SEC document |
| February 11, 2026 Filed Feb 13, 2026 22:47 UTC |
Garfield AlastairChief Scientific Officer
|
GrantRestricted Stock Units · Derivative | 16,650 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-26-015397 · tm266366-2_4seq1.xml · derivative · entry 1 Garfield Alastair · CIK 0002027261 · Chief Scientific Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,650 Underlying: Common Stock · 16,650 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Issuer common stock. F2 · derivative.exercise_date: The restricted stock units vest as to 25% of the total shares on each of February 1, 2027, February 1, 2028, February 1, 2029 and February 1, 2030. The restricted stock units have no expiration date. F2 · derivative.expiration_date: The restricted stock units vest as to 25% of the total shares on each of February 1, 2027, February 1, 2028, February 1, 2029 and February 1, 2030. The restricted stock units have no expiration date. Read SEC document |
| February 11, 2026 Filed Feb 13, 2026 22:45 UTC |
Cramer Pamela J.Chief Human Resources Officer
|
GrantStock Options (Right to Buy) · Derivative | 17,500 | $0.00 Strike: $98.47 | $0.00 |
DisclosureSEC source: 0001104659-26-015396 · tm266366-1_4seq1.xml · derivative · entry 2 Cramer Pamela J. · CIK 0001873517 · Chief Human Resources Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,500 Underlying: Common Stock · 17,500 shares Expires 2036-02-10 F3 · derivative.exercise_date: The stock options were granted on February 11, 2026. The options vest and become exercisable in 16 substantially equal installments upon the Reporting Person's completion of each three full months of successive service to the Issuer following the grant date. Read SEC document |
| February 11, 2026 Filed Feb 13, 2026 22:45 UTC |
Cramer Pamela J.Chief Human Resources Officer
|
GrantRestricted Stock Units · Derivative | 11,650 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-26-015396 · tm266366-1_4seq1.xml · derivative · entry 1 Cramer Pamela J. · CIK 0001873517 · Chief Human Resources Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,650 Underlying: Common Stock · 11,650 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Issuer common stock. F2 · derivative.exercise_date: The restricted stock units vest as to 25% of the total shares on each of February 1, 2027, February 1, 2028, February 1, 2029 and February 1, 2030. The restricted stock units have no expiration date. F2 · derivative.expiration_date: The restricted stock units vest as to 25% of the total shares on each of February 1, 2027, February 1, 2028, February 1, 2029 and February 1, 2030. The restricted stock units have no expiration date. Read SEC document |
| February 11, 2026 Filed Feb 13, 2026 22:49 UTC |
Lee Jennifer KaydenEVP, Head of North America
|
GrantStock Options (Right to Buy) · Derivative | 32,500 | $0.00 Strike: $98.47 | $0.00 |
DisclosureSEC source: 0001104659-26-015399 · tm266366-4_4seq1.xml · derivative · entry 2 Lee Jennifer Kayden · CIK 0001801372 · EVP, Head of North America 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 32,500 Underlying: Common Stock · 32,500 shares Expires 2036-02-10 F3 · derivative.exercise_date: The stock options were granted on February 11, 2026. The options vest and become exercisable in 16 substantially equal installments upon the Reporting Person's completion of each three full months of successive service to the Issuer following the grant date. Read SEC document |
| February 11, 2026 Filed Feb 13, 2026 22:49 UTC |
Lee Jennifer KaydenEVP, Head of North America
|
GrantRestricted Stock Units · Derivative | 21,650 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-26-015399 · tm266366-4_4seq1.xml · derivative · entry 1 Lee Jennifer Kayden · CIK 0001801372 · EVP, Head of North America 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 21,650 Underlying: Common Stock · 21,650 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Issuer common stock. F2 · derivative.exercise_date: The restricted stock units vest as to 25% of the total shares on each of February 1, 2027, February 1, 2028, February 1, 2029 and February 1, 2030. The restricted stock units have no expiration date. F2 · derivative.expiration_date: The restricted stock units vest as to 25% of the total shares on each of February 1, 2027, February 1, 2028, February 1, 2029 and February 1, 2030. The restricted stock units have no expiration date. Read SEC document |
| February 11, 2026 Filed Feb 13, 2026 22:48 UTC |
German Christopher PaulCorporate Controller & CAO
|
GrantRestricted Stock Units · Derivative | 5,215 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-26-015398 · tm266366-3_4seq1.xml · derivative · entry 1 German Christopher Paul · CIK 0001260835 · Corporate Controller & CAO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,215 Underlying: Common Stock · 5,215 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Issuer common stock. F2 · derivative.exercise_date: The restricted stock units vest as to 25% of the total shares on each of February 1, 2027, February 1, 2028, February 1, 2029 and February 1, 2030. The restricted stock units have no expiration date. F2 · derivative.expiration_date: The restricted stock units vest as to 25% of the total shares on each of February 1, 2027, February 1, 2028, February 1, 2029 and February 1, 2030. The restricted stock units have no expiration date. Read SEC document |
| February 11, 2026 Filed Feb 13, 2026 22:52 UTC |
Meeker David PDirector · President and CEO
|
GrantStock Options (Right to Buy) · Derivative | 107,850 | $0.00 Strike: $98.47 | $0.00 |
DisclosureSEC source: 0001104659-26-015403 · tm266366-6_4seq1.xml · derivative · entry 2 Meeker David P · CIK 0001385155 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 107,850 Underlying: Common Stock · 107,850 shares Expires 2036-02-10 F3 · derivative.exercise_date: The stock options were granted on February 11, 2026. The options vest and become exercisable in 16 substantially equal installments upon the Reporting Person's completion of each three full months of successive service to the Issuer following the grant date. Read SEC document |
| February 11, 2026 Filed Feb 13, 2026 22:52 UTC |
Meeker David PDirector · President and CEO
|
GrantRestricted Stock Units · Derivative | 71,900 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-26-015403 · tm266366-6_4seq1.xml · derivative · entry 1 Meeker David P · CIK 0001385155 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 71,900 Underlying: Common Stock · 71,900 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Issuer common stock. F2 · derivative.exercise_date: The restricted stock units vest as to 25% of the total shares on each of February 1, 2027, February 1, 2028, February 1, 2029 and February 1, 2030. The restricted stock units have no expiration date. F2 · derivative.expiration_date: The restricted stock units vest as to 25% of the total shares on each of February 1, 2027, February 1, 2028, February 1, 2029 and February 1, 2030. The restricted stock units have no expiration date. Read SEC document |
| February 11, 2026 Filed Feb 13, 2026 22:53 UTC |
Shulman JosephChief Technical Officer
|
GrantStock Options (Right to Buy) · Derivative | 22,500 | $0.00 Strike: $98.47 | $0.00 |
DisclosureSEC source: 0001104659-26-015405 · tm266366-7_4seq1.xml · derivative · entry 2 Shulman Joseph · CIK 0001909855 · Chief Technical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 22,500 Underlying: Common Stock · 22,500 shares Expires 2036-02-10 F3 · derivative.exercise_date: The stock options were granted on February 11, 2026. The options vest and become exercisable in 16 substantially equal installments upon the Reporting Person's completion of each three full months of successive service to the Issuer following the grant date. Read SEC document |
| February 11, 2026 Filed Feb 13, 2026 22:53 UTC |
Shulman JosephChief Technical Officer
|
GrantRestricted Stock Units · Derivative | 15,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-26-015405 · tm266366-7_4seq1.xml · derivative · entry 1 Shulman Joseph · CIK 0001909855 · Chief Technical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,000 Underlying: Common Stock · 15,000 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Issuer common stock. F2 · derivative.exercise_date: The restricted stock units vest as to 25% of the total shares on each of February 1, 2027, February 1, 2028, February 1, 2029 and February 1, 2030. The restricted stock units have no expiration date. F2 · derivative.expiration_date: The restricted stock units vest as to 25% of the total shares on each of February 1, 2027, February 1, 2028, February 1, 2029 and February 1, 2030. The restricted stock units have no expiration date. Read SEC document |
| February 11, 2026 Filed Feb 13, 2026 22:50 UTC |
Mazabraud YannEVP, Head of International
|
GrantRestricted Stock Units · Derivative | 23,350 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-26-015400 · tm266366-5_4seq1.xml · derivative · entry 1 Mazabraud Yann · CIK 0001774702 · EVP, Head of International 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 23,350 Underlying: Common Stock · 23,350 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Issuer common stock. F2 · derivative.exercise_date: The restricted stock units vest as to 25% of the total shares on each of March 1, 2027, February 1, 2028, February 1, 2029 and February 1, 2030. The restricted stock units have no expiration date. F2 · derivative.expiration_date: The restricted stock units vest as to 25% of the total shares on each of March 1, 2027, February 1, 2028, February 1, 2029 and February 1, 2030. The restricted stock units have no expiration date. Read SEC document |
| February 10, 2026 Filed Feb 13, 2026 01:56 UTC |
Smith Hunter CChief Financial Officer
|
SaleCommon Stock | 100 | $104.76 | $10,476.00 |
DisclosureSEC source: 0001104659-26-014546 · tm266263-1_4seq1.xml · nonDerivative · entry 3 Smith Hunter C · CIK 0001636385 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 122,824 F1 · kind: The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on February 28, 2025. Read SEC document |
| February 10, 2026 Filed Feb 13, 2026 01:56 UTC |
Smith Hunter CChief Financial Officer
|
SaleCommon Stock | 700 | $103.68 | $72,573.69 |
DisclosureSEC source: 0001104659-26-014546 · tm266263-1_4seq1.xml · nonDerivative · entry 2 Smith Hunter C · CIK 0001636385 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 122,924 F1 · kind: The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on February 28, 2025. F3 · price: The price reported in Column 4 is a weighted average price. The securities were sold in multiple transactions at prices ranging from $103.23 to $103.98 per common stock. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| February 10, 2026 Filed Feb 13, 2026 01:56 UTC |
Smith Hunter CChief Financial Officer
|
SaleCommon Stock | 1,913 | $102.66 | $196,379.78 |
DisclosureSEC source: 0001104659-26-014546 · tm266263-1_4seq1.xml · nonDerivative · entry 1 Smith Hunter C · CIK 0001636385 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 123,624 F1 · kind: The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on February 28, 2025. F2 · price: The price reported in Column 4 is a weighted average price. The securities were sold in multiple transactions at prices ranging from $$102.09 to $103.02 per common stock. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| February 05, 2026 Filed Feb 6, 2026 23:38 UTC |
Smith Hunter CChief Financial Officer
|
SaleCommon Stock | 3,381 | $106.06 | $358,599.00 |
DisclosureSEC source: 0001104659-26-011651 · tm265467-1_4seq1.xml · nonDerivative · entry 4 Smith Hunter C · CIK 0001636385 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 125,537 F1 · kind: The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on February 28, 2025. Read SEC document |
| February 04, 2026 Filed Feb 6, 2026 23:38 UTC |
Smith Hunter CChief Financial Officer
|
SaleCommon Stock | 747 | $107.67 | $80,426.05 |
DisclosureSEC source: 0001104659-26-011651 · tm265467-1_4seq1.xml · nonDerivative · entry 3 Smith Hunter C · CIK 0001636385 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 128,918 F1 · kind: The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on February 28, 2025. F4 · price: The price reported in Column 4 is a weighted average price. The securities were sold in multiple transactions at prices ranging from $107.32 to $108.08 per common stock. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| February 04, 2026 Filed Feb 6, 2026 23:38 UTC |
Smith Hunter CChief Financial Officer
|
SaleCommon Stock | 1,000 | $106.60 | $106,604.00 |
DisclosureSEC source: 0001104659-26-011651 · tm265467-1_4seq1.xml · nonDerivative · entry 2 Smith Hunter C · CIK 0001636385 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 129,665 F1 · kind: The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on February 28, 2025. F3 · price: The price reported in Column 4 is a weighted average price. The securities were sold in multiple transactions at prices ranging from $106.31 to $107.15 per common stock. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| February 04, 2026 Filed Feb 6, 2026 23:38 UTC |
Smith Hunter CChief Financial Officer
|
SaleCommon Stock | 1,500 | $104.74 | $157,115.10 |
DisclosureSEC source: 0001104659-26-011651 · tm265467-1_4seq1.xml · nonDerivative · entry 1 Smith Hunter C · CIK 0001636385 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 130,665 F1 · kind: The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on February 28, 2025. F2 · price: The price reported in Column 4 is a weighted average price. The securities were sold in multiple transactions at prices ranging from $104.34 to $104.99 per common stock. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| February 01, 2026 Filed Feb 3, 2026 21:31 UTC |
Garfield AlastairChief Scientific Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 6,663 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-26-009764 · tm264963-2_4seq1.xml · derivative · entry 3 Garfield Alastair · CIK 0002027261 · Chief Scientific Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 19,987 Underlying: Common Stock · 6,663 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Issuer common stock. F3 · derivative.exercise_date: The restricted stock units vest as to 25% of the total shares on each of February 1, 2026, February 1, 2027, February 1, 2028 and February 1, 2029. The restricted stock units have no expiration date. F3 · derivative.expiration_date: The restricted stock units vest as to 25% of the total shares on each of February 1, 2026, February 1, 2027, February 1, 2028 and February 1, 2029. The restricted stock units have no expiration date. Read SEC document |
| February 01, 2026 Filed Feb 3, 2026 21:31 UTC |
Garfield AlastairChief Scientific Officer
|
Tax withholdingCommon Stock | 2,026 | $108.99 | $220,813.74 |
DisclosureSEC source: 0001104659-26-009764 · tm264963-2_4seq1.xml · nonDerivative · entry 2 Garfield Alastair · CIK 0002027261 · Chief Scientific Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,763 F2 · kind: These shares were withheld for payment of the withholding taxes upon the vesting of the restricted stock units reported herein. Read SEC document |
| February 01, 2026 Filed Feb 3, 2026 21:31 UTC |
Garfield AlastairChief Scientific Officer
|
Exercise / conversionCommon Stock | 6,663 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001104659-26-009764 · tm264963-2_4seq1.xml · nonDerivative · entry 1 Garfield Alastair · CIK 0002027261 · Chief Scientific Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,789 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of Issuer common stock. Read SEC document |
| February 01, 2026 Filed Feb 3, 2026 21:30 UTC |
Cramer Pamela J.Chief Human Resources Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 5,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-26-009758 · tm264963-1_4seq1.xml · derivative · entry 6 Cramer Pamela J. · CIK 0001873517 · Chief Human Resources Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,000 Underlying: Common Stock · 5,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Issuer common stock. F6 · derivative.exercise_date: The restricted stock units vest as to 25% of the total shares on each of February 1, 2026, February 1, 2027, February 1, 2028 and February 1, 2029. The restricted stock units have no expiration date. F6 · derivative.expiration_date: The restricted stock units vest as to 25% of the total shares on each of February 1, 2026, February 1, 2027, February 1, 2028 and February 1, 2029. The restricted stock units have no expiration date. Read SEC document |
| February 01, 2026 Filed Feb 3, 2026 21:30 UTC |
Cramer Pamela J.Chief Human Resources Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 3,300 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-26-009758 · tm264963-1_4seq1.xml · derivative · entry 5 Cramer Pamela J. · CIK 0001873517 · Chief Human Resources Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,600 Underlying: Common Stock · 3,300 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Issuer common stock. F5 · derivative.exercise_date: The restricted stock units vest as to 25% of the total shares on each of February 16, 2025, February 1, 2026, February 1, 2027 and February 1, 2028. The restricted stock units have no expiration date. F5 · derivative.expiration_date: The restricted stock units vest as to 25% of the total shares on each of February 16, 2025, February 1, 2026, February 1, 2027 and February 1, 2028. The restricted stock units have no expiration date. Read SEC document |
| February 01, 2026 Filed Feb 3, 2026 21:30 UTC |
Cramer Pamela J.Chief Human Resources Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 2,650 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-26-009758 · tm264963-1_4seq1.xml · derivative · entry 4 Cramer Pamela J. · CIK 0001873517 · Chief Human Resources Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,650 Underlying: Common Stock · 2,650 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Issuer common stock. F4 · derivative.exercise_date: The restricted stock units vest as to 25% of the total shares on each of February 1, 2024, February 1, 2025, February 1, 2026 and February 1, 2027. The restricted stock units have no expiration date. F4 · derivative.expiration_date: The restricted stock units vest as to 25% of the total shares on each of February 1, 2024, February 1, 2025, February 1, 2026 and February 1, 2027. The restricted stock units have no expiration date. Read SEC document |
| February 01, 2026 Filed Feb 3, 2026 21:30 UTC |
Cramer Pamela J.Chief Human Resources Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 2,343 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-26-009758 · tm264963-1_4seq1.xml · derivative · entry 3 Cramer Pamela J. · CIK 0001873517 · Chief Human Resources Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,343 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Issuer common stock. F3 · derivative.exercise_date: The restricted stock units vest as to 25% of the total shares on each of February 9, 2023, February 9, 2024, February 9, 2025 and February 1, 2026. The restricted stock units have no expiration date. F3 · derivative.expiration_date: The restricted stock units vest as to 25% of the total shares on each of February 9, 2023, February 9, 2024, February 9, 2025 and February 1, 2026. The restricted stock units have no expiration date. Read SEC document |
| February 01, 2026 Filed Feb 3, 2026 21:30 UTC |
Cramer Pamela J.Chief Human Resources Officer
|
Tax withholdingCommon Stock | 4,731 | $108.99 | $515,631.69 |
DisclosureSEC source: 0001104659-26-009758 · tm264963-1_4seq1.xml · nonDerivative · entry 2 Cramer Pamela J. · CIK 0001873517 · Chief Human Resources Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 29,376 F2 · kind: These shares were withheld for payment of the withholding taxes upon the vesting of the restricted stock units reported herein. Read SEC document |
| February 01, 2026 Filed Feb 3, 2026 21:30 UTC |
Cramer Pamela J.Chief Human Resources Officer
|
Exercise / conversionCommon Stock | 13,293 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001104659-26-009758 · tm264963-1_4seq1.xml · nonDerivative · entry 1 Cramer Pamela J. · CIK 0001873517 · Chief Human Resources Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 34,107 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of Issuer common stock. Read SEC document |
| February 01, 2026 Filed Feb 3, 2026 21:33 UTC |
Lee Jennifer KaydenEVP, Head of North America
|
Exercise / conversionRestricted Stock Units · Derivative | 9,163 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-26-009767 · tm264963-4_4seq1.xml · derivative · entry 6 Lee Jennifer Kayden · CIK 0001801372 · EVP, Head of North America 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 27,487 Underlying: Common Stock · 9,163 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Issuer common stock. F6 · derivative.exercise_date: The restricted stock units vest as to 25% of the total shares on each of February 1, 2026, February 1, 2027, February 1, 2028 and February 1, 2029. The restricted stock units have no expiration date. F6 · derivative.expiration_date: The restricted stock units vest as to 25% of the total shares on each of February 1, 2026, February 1, 2027, February 1, 2028 and February 1, 2029. The restricted stock units have no expiration date. Read SEC document |
| February 01, 2026 Filed Feb 3, 2026 21:33 UTC |
Lee Jennifer KaydenEVP, Head of North America
|
Exercise / conversionRestricted Stock Units · Derivative | 5,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-26-009767 · tm264963-4_4seq1.xml · derivative · entry 5 Lee Jennifer Kayden · CIK 0001801372 · EVP, Head of North America 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,000 Underlying: Common Stock · 5,500 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Issuer common stock. F5 · derivative.exercise_date: The restricted stock units vest as to 25% of the total shares on each of February 16, 2025, February 1, 2026, February 1, 2027 and February 1, 2028. The restricted stock units have no expiration date. F5 · derivative.expiration_date: The restricted stock units vest as to 25% of the total shares on each of February 16, 2025, February 1, 2026, February 1, 2027 and February 1, 2028. The restricted stock units have no expiration date. Read SEC document |
| February 01, 2026 Filed Feb 3, 2026 21:33 UTC |
Lee Jennifer KaydenEVP, Head of North America
|
Exercise / conversionRestricted Stock Units · Derivative | 4,512 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-26-009767 · tm264963-4_4seq1.xml · derivative · entry 4 Lee Jennifer Kayden · CIK 0001801372 · EVP, Head of North America 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,512 Underlying: Common Stock · 4,512 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Issuer common stock. F4 · derivative.exercise_date: The restricted stock units vest as to 25% of the total shares on each of February 1, 2024, February 1, 2025, February 1, 2026 and February 1, 2027. The restricted stock units have no expiration date. F4 · derivative.expiration_date: The restricted stock units vest as to 25% of the total shares on each of February 1, 2024, February 1, 2025, February 1, 2026 and February 1, 2027. The restricted stock units have no expiration date. Read SEC document |
| February 01, 2026 Filed Feb 3, 2026 21:33 UTC |
Lee Jennifer KaydenEVP, Head of North America
|
Exercise / conversionRestricted Stock Units · Derivative | 3,437 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-26-009767 · tm264963-4_4seq1.xml · derivative · entry 3 Lee Jennifer Kayden · CIK 0001801372 · EVP, Head of North America 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,437 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Issuer common stock. F3 · derivative.exercise_date: The restricted stock units vest as to 25% of the total shares on each of February 9, 2023, February 9, 2024, February 9, 2025 and February 1, 2026. The restricted stock units have no expiration date. F3 · derivative.expiration_date: The restricted stock units vest as to 25% of the total shares on each of February 9, 2023, February 9, 2024, February 9, 2025 and February 1, 2026. The restricted stock units have no expiration date. Read SEC document |
| February 01, 2026 Filed Feb 3, 2026 21:33 UTC |
Lee Jennifer KaydenEVP, Head of North America
|
Tax withholdingCommon Stock | 9,237 | $108.99 | $1,006,740.63 |
DisclosureSEC source: 0001104659-26-009767 · tm264963-4_4seq1.xml · nonDerivative · entry 2 Lee Jennifer Kayden · CIK 0001801372 · EVP, Head of North America 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 19,233 F2 · kind: These shares were withheld for payment of the withholding taxes upon the vesting of the restricted stock units reported herein. Read SEC document |
| February 01, 2026 Filed Feb 3, 2026 21:33 UTC |
Lee Jennifer KaydenEVP, Head of North America
|
Exercise / conversionCommon Stock | 22,612 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001104659-26-009767 · tm264963-4_4seq1.xml · nonDerivative · entry 1 Lee Jennifer Kayden · CIK 0001801372 · EVP, Head of North America 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 28,470 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of Issuer common stock. Read SEC document |
| February 01, 2026 Filed Feb 3, 2026 21:32 UTC |
German Christopher PaulCorporate Controller & CAO
|
Exercise / conversionRestricted Stock Units · Derivative | 1,807 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-26-009766 · tm264963-3_4seq1.xml · derivative · entry 4 German Christopher Paul · CIK 0001260835 · Corporate Controller & CAO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,418 Underlying: Common Stock · 1,807 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Issuer common stock. F5 · derivative.exercise_date: The restricted stock units vest as to 25% of the total shares on each of February 1, 2026, February 1, 2027, February 1, 2028 and February 1, 2029. The restricted stock units have no expiration date. F5 · derivative.expiration_date: The restricted stock units vest as to 25% of the total shares on each of February 1, 2026, February 1, 2027, February 1, 2028 and February 1, 2029. The restricted stock units have no expiration date. Read SEC document |
| February 01, 2026 Filed Feb 3, 2026 21:32 UTC |
German Christopher PaulCorporate Controller & CAO
|
Exercise / conversionRestricted Stock Units · Derivative | 1,806 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-26-009766 · tm264963-3_4seq1.xml · derivative · entry 3 German Christopher Paul · CIK 0001260835 · Corporate Controller & CAO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,612 Underlying: Common Stock · 1,806 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Issuer common stock. F4 · derivative.exercise_date: The restricted stock units vest as to 25% of the total shares on each of February 16, 2025, February 1, 2026, February 1, 2027 and February 1, 2028. The restricted stock units have no expiration date. F4 · derivative.expiration_date: The restricted stock units vest as to 25% of the total shares on each of February 16, 2025, February 1, 2026, February 1, 2027 and February 1, 2028. The restricted stock units have no expiration date. Read SEC document |
| February 01, 2026 Filed Feb 3, 2026 21:32 UTC |
German Christopher PaulCorporate Controller & CAO
|
Tax withholdingCommon Stock | 1,138 | $108.99 | $124,030.62 |
DisclosureSEC source: 0001104659-26-009766 · tm264963-3_4seq1.xml · nonDerivative · entry 2 German Christopher Paul · CIK 0001260835 · Corporate Controller & CAO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,433 F3 · kind: These shares were withheld for payment of the withholding taxes upon the vesting of the restricted stock units reported herein. Read SEC document |
| February 01, 2026 Filed Feb 3, 2026 21:32 UTC |
German Christopher PaulCorporate Controller & CAO
|
Exercise / conversionCommon Stock | 3,613 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001104659-26-009766 · tm264963-3_4seq1.xml · nonDerivative · entry 1 German Christopher Paul · CIK 0001260835 · Corporate Controller & CAO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,571 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of Issuer common stock. F2 · balance_after: Includes 36 shares of Common Stock purchased pursuant to the Rhythm Pharmaceuticals, Inc. Employee Stock Purchase Plan. Read SEC document |
| February 01, 2026 Filed Feb 3, 2026 21:34 UTC |
Meeker David PDirector · President and CEO
|
Exercise / conversionRestricted Stock Units · Derivative | 33,338 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-26-009768 · tm264963-6_4seq1.xml · derivative · entry 5 Meeker David P · CIK 0001385155 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 100,012 Underlying: Common Stock · 33,338 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Issuer common stock. F5 · derivative.exercise_date: The restricted stock units vest as to 25% of the total shares on each of February 1, 2026, February 1, 2027, February 1, 2028 and February 1, 2029. The restricted stock units have no expiration date. F5 · derivative.expiration_date: The restricted stock units vest as to 25% of the total shares on each of February 1, 2026, February 1, 2027, February 1, 2028 and February 1, 2029. The restricted stock units have no expiration date. Read SEC document |
| February 01, 2026 Filed Feb 3, 2026 21:34 UTC |
Meeker David PDirector · President and CEO
|
Exercise / conversionRestricted Stock Units · Derivative | 21,250 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-26-009768 · tm264963-6_4seq1.xml · derivative · entry 4 Meeker David P · CIK 0001385155 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 42,500 Underlying: Common Stock · 21,250 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Issuer common stock. F4 · derivative.exercise_date: The restricted stock units vest as to 25% of the total shares on each of February 16, 2025, February 1, 2026, February 1, 2027 and February 1, 2028. The restricted stock units have no expiration date. F4 · derivative.expiration_date: The restricted stock units vest as to 25% of the total shares on each of February 16, 2025, February 1, 2026, February 1, 2027 and February 1, 2028. The restricted stock units have no expiration date. Read SEC document |
| February 01, 2026 Filed Feb 3, 2026 21:34 UTC |
Meeker David PDirector · President and CEO
|
Exercise / conversionRestricted Stock Units · Derivative | 14,125 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-26-009768 · tm264963-6_4seq1.xml · derivative · entry 3 Meeker David P · CIK 0001385155 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,125 Underlying: Common Stock · 14,125 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Issuer common stock. F3 · derivative.exercise_date: The restricted stock units vest as to 25% of the total shares on each of February 1, 2024, February 1, 2025, February 1, 2026 and February 1, 2027. The restricted stock units have no expiration date. F3 · derivative.expiration_date: The restricted stock units vest as to 25% of the total shares on each of February 1, 2024, February 1, 2025, February 1, 2026 and February 1, 2027. The restricted stock units have no expiration date. Read SEC document |
| February 01, 2026 Filed Feb 3, 2026 21:34 UTC |
Meeker David PDirector · President and CEO
|
Tax withholdingCommon Stock | 31,522 | $108.99 | $3,435,582.78 |
DisclosureSEC source: 0001104659-26-009768 · tm264963-6_4seq1.xml · nonDerivative · entry 2 Meeker David P · CIK 0001385155 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 239,016 F2 · kind: These shares were withheld for payment of the withholding taxes upon the vesting of the restricted stock units reported herein. Read SEC document |
| February 01, 2026 Filed Feb 3, 2026 21:34 UTC |
Meeker David PDirector · President and CEO
|
Exercise / conversionCommon Stock | 68,713 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001104659-26-009768 · tm264963-6_4seq1.xml · nonDerivative · entry 1 Meeker David P · CIK 0001385155 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 270,538 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of Issuer common stock. Read SEC document |
| February 01, 2026 Filed Feb 3, 2026 21:36 UTC |
Smith Hunter CChief Financial Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 10,413 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-26-009770 · tm264963-8_4seq1.xml · derivative · entry 6 Smith Hunter C · CIK 0001636385 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 31,237 Underlying: Common Stock · 10,413 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Issuer common stock. F6 · derivative.exercise_date: The restricted stock units vest as to 25% of the total shares on each of February 1, 2026, February 1, 2027, February 1, 2028 and February 1, 2029. The restricted stock units have no expiration date. F6 · derivative.expiration_date: The restricted stock units vest as to 25% of the total shares on each of February 1, 2026, February 1, 2027, February 1, 2028 and February 1, 2029. The restricted stock units have no expiration date. Read SEC document |
| February 01, 2026 Filed Feb 3, 2026 21:36 UTC |
Smith Hunter CChief Financial Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 6,600 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-26-009770 · tm264963-8_4seq1.xml · derivative · entry 5 Smith Hunter C · CIK 0001636385 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,200 Underlying: Common Stock · 6,600 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Issuer common stock. F5 · derivative.exercise_date: The restricted stock units vest as to 25% of the total shares on each of February 16, 2025, February 1, 2026, February 1, 2027 and February 1, 2028. The restricted stock units have no expiration date. F5 · derivative.expiration_date: The restricted stock units vest as to 25% of the total shares on each of February 16, 2025, February 1, 2026, February 1, 2027 and February 1, 2028. The restricted stock units have no expiration date. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.